🇺🇸 FDA
Patent

US 10780106

Method for treating NASH accompanied by fibrosis using Cl-IB-MECA

granted A61KA61K31/7076A61K9/0053

Quick answer

US patent 10780106 (Method for treating NASH accompanied by fibrosis using Cl-IB-MECA) held by CAN-FITE BIOPHARMA LTD. expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAN-FITE BIOPHARMA LTD.
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/7076, A61K9/0053, A61P, A61P1/16